Nomura maintains buy on Dr Reddy's Lab
Nomura cut
target price on Dr Reddy's Lab to Rs 4,346 from Rs 4,919 earlier. Dr
Reddy's is a play on the US generics and emerging market pharma growth.
It is also a play on the biosimilar opportunity, which is likely to
evolve over the next five years.